A new climate King?

King Charles III has a rich history of climate activism; however, there exists concerns surrounding whether he can forego his passions to fulfil his role as King. While his climate equivocations have amassed support, he may be the most paradoxical climate activist to date - he demands government action to reduce global warming but continues to travel the world in his private jet and array of high-end cars.


As Prince of Wales, he undertook a lot of charitable work principally on climate change. For instance, he launched Terra Carta which aimed to promote private sector sustainability; built an offshore wind farm in Scotland; launched the Sustainable Markets Initiative and the list goes on. He has sent '44 black spider letters' urging Ministers to act on governmental issues. His political urgency is evident in his speeches on the environmental crisis at the Glasgow COP 26 summit and the World Economic Forum.



King Charles III Prince of Wales

Source: AP Photo/Alastair Grant


Whether his deep-rooted passion for environmental change will flow into his rhetoric as King is unlikely. The UK operates under a constitutional monarchy and therefore King Charles is not afforded any specific legislative or political power. Yet, the sovereign's sway is subject to deliberate opacity, particularly between the advice afforded to the Prime Minister by the King. What is certain is that royal assent must be given to legislation created by Parliament, however, in modern times there has been no evidence that this authority has been much use. This notion is especially true when considering the centrality of UK's representational democracy.


The King, however, does operate as a symbol of national identity, unity, and pride. As such, the rhetoric employed by the King has considerable sway. Despite the King's history with environmental causes he bluntly stated a number of years ago, "clearly I won't be able to do the same things I've done as heir", adding he would not engage in political issues. In a recent speech concerning the death of The Queen he promised to "uphold the constitutional principles at the heart of the nation". Whether this rules out the possibility of whether he will continue to either directly or indirectly engage in raising matters such as climate change is not certain.


Such uncertainty is compounded by the fact that UK Prime Minister Liz Truss has regularly expressed doubt about the nation's renewable energy policies, and controversially pledged to ramp up fossil fuel investment. In fact, she appointed an energy secretary who has questioned whether climate change is caused by human activity and if the world should try to even prevent it.


So, the question remains: how neutral will King Charles III be?

Subscribe to our newsletter

Disclaimer: This article does not constitute financial advice nor a recommendation to invest in the securities listed. The information presented is intended to be of a factual nature only. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing.

Is a Share Advisor

right for you?

May 8, 2026
Learn how professional investors analyse earnings reports by assessing revenue quality, margins, cash flow, balance sheet strength and management guidance.
By Debie Deslate May 7, 2026
Global energy risks are rising. Australia just committed $10.7 billion to respond. A closer look at the economic risks driving Australia’s push for greater fuel security.
May 6, 2026
The RBA has lifted rates to 4.35%. Here’s what it means for households, inflation, markets, sector performance and the outlook for Australian investors.
May 6, 2026
About The a2 Milk Co Ltd The a2 Milk Company Limited, together with its subsidiaries, sells A2-type protein type branded milk and related products in Australia, New Zealand, China, rest of Asia, and the United States. The company offers infant milk formula; other nutritional products and milk; manufactures and sells nutritional and ingredients products, as well as provides rent, royalty, and licensing services. It offers its products under the a2 Milk and a2 Platinum brands. The company was formerly known as A2 Corporation Limited and changed its name to The a2 Milk Company Limited in April 2014. The a2 Milk Company Limited was incorporated in 2000 and is based in Auckland, New Zealand. Source: EODHD Key Stats
May 5, 2026
About Meta Platforms Inc Meta Platforms, Inc. engages in the development of products that enable people to connect and share with friends and family through mobile devices, personal computers, virtual reality (VR) headsets, and AI glasses in the United States, Canada, Europe, Asia-Pacific, and internationally. It operates through two segments, Family of Apps (FoA) and Reality Labs (RL). The FoA segment offers Facebook, which enables people to build community through feed, reels, stories, groups, marketplace, and other; Instagram that brings people closer through Instagram feed, stories, reels, live, and messaging; Messenger, a messaging application for people to connect with friends, family, communities, and businesses across platforms and devices through text, audio, and video calls; Meta AI, an assistant that's available across apps, as a stand-alone app, on AI glasses, and on the web; Threads, an application for text-based updates and public conversations; and WhatsApp, a messaging application that is used by people and businesses to communicate and transact in a private way. The RL segment provides virtual and augmented reality products, including consumer hardware, software, and content that help people feel connected anytime and anywhere, as well as Meta Quest devices that enable social experiences across gaming, fitness, entertainment, and more. The segment also includes wearables such as AI glasses like Ray Ban Meta and Oakley Meta glasses, featuring Meta AI for advanced conversational and hands free interaction; and the Meta Ray Ban Display, which combines AI glasses with an integrated lens display and the Meta Neural Band, a wrist worn device using electromyography that lets people control their AI glasses through neuromuscular signals. The company was formerly known as Facebook, Inc. and changed its name to Meta Platforms, Inc. in October 2021. The company was incorporated in 2004 and is headquartered in Menlo Park, California. Source:EODHD Key Stats
May 5, 2026
About Amazon.com Inc Amazon.com, Inc. engages in the retail sale of consumer products, advertising, and subscriptions service through online and physical stores in North America and internationally. The company operates through three segments: North America, International, and Amazon Web Services (AWS). It also manufactures and sells electronic devices, including Kindle, fire tablets, fire TVs, echo, ring, blink, and eero; and develops and produces media content. In addition, the company offers programs that enable sellers to sell their products in its stores; and programs that allow authors, independent publishers, musicians, filmmakers, Twitch streamers, skill and app developers, and others to publish and sell content. Further, it provides compute, storage, Artificial intelligence, database, analytics, machine learning, and other services, as well as advertising services through programs, such as sponsored ads, display, and video advertising. Additionally, the company offers Amazon Prime, a membership program. The company's products offered through its stores include merchandise and content purchased for resale and products offered by third-party sellers. It serves consumers, sellers, developers, enterprises, content creators, advertisers, and employees. The company was incorporated in 1994 and is headquartered in Seattle, Washington. Source:EODHD Key Stats
May 1, 2026
Earnings may beat expectations, but guidance drives markets. Learn how to read forward outlooks, tone and signals to better interpret stock price reactions.
May 1, 2026
About Visa Inc. Visa Inc. operates as a payment technology company in the United States and internationally. The company operates VisaNet, a transaction processing network that enables authorization, clearing, and settlement of payment transactions. It also offers credit, debit, and prepaid card products; tap to pay, tokenization, and click to pay services; Visa Direct, a solution that facilitates the delivery of funds to eligible cards, bank accounts, and digital wallets; Visa B2B Connect, a multilateral business-to-business cross-border payments network; Visa Cross-Border Solution, a cross-border consumer payments solution; and Visa DPS that provides a range of value-added services, including fraud mitigation, dispute management, data analytics, campaign management, a suite of digital solutions, and contact center services. The company also provides acceptance solutions, which include Cybersource and Authorize.net that provides new and enhanced payment integrations with ecommerce platforms, enabling sellers and acquirers to offer tailored commerce experiences; risk and identity solutions, such as Visa Advanced Authorization, Visa Secure, Visa Consumer Authentication Service, Visa Protect Authentication Intelligence, and Visa Provisioning Intelligence; and Visa Consulting and Analytics, a payment consulting advisory services. It provides its services under the Visa, Visa Electron, Interlink, V PAY, and PLUS brands. The company serves merchants, financial institutions, and government entities. Visa Inc. was founded in 1958 and is headquartered in San Francisco, California. Source:EODHD Key Stats
May 1, 2026
About Telix Pharmaceuticals Ltd Telix Pharmaceuticals Limited, a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals. The company operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic product candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC), which is in a Phase 3 clinical trial in patients with advanced prostate cancer. The company develops TLX250, an rADC for treating advanced metastatic kidney cancer; TLX101, a systemic therapy for the treatment of glioblastoma; TLX66, a product candidate for bone marrow conditioning for hematopoietic stem cell transplant conditioning; and Illuccix and Gozellix for the treatment of prostate cancer. The company is also developing TLX592, a prostate cancer therapy candidate for targeted alpha therapy based on its proprietary RADmAb-engineered antibody technology; TLX252 for the treatment of patients with advanced metastatic kidney cancer; TLX400, a bladder fibroblast activation protein for treating various tumors; TLX102, a large amino acid transporter-targeting small molecule-based alpha therapy candidate for the treatment of glioblastoma and multiple myeloma; TLX300 for treating soft tissue sarcoma; and TLX090, a bone-seeking agent for bone metastases and pain palliation. In addition, it is developing BiPASS, which is in Phase 3 clinical trial for prostate cancer diagnosis; AlFluor, a novel PET radiochemistry solution; TLX250-Px, a PET diagnostic imaging agent; and TLX101-Px, a radiolabeled amino acid PET agent. It operates in Australia, Belgium, Canada, the United Kingdom, the United States, and internationally. The company has strategic collaboration with University Hospital Essen. The company was founded in 2015 and is headquartered in North Melbourne, Australia. Source:EODHD Key Stats
April 30, 2026
The UAE leaves OPEC on 1 May. Oil prices did not move. Here is why the near-term calm is masking a structural shift investors should not ignore.